New Clinical Advances in Pediatric Asthma

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Clinical Pediatrics".

Deadline for manuscript submissions: 15 December 2025 | Viewed by 24

Special Issue Editor


E-Mail
Guest Editor
1. Medical Faculty, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia
2. Prima Nova, Zagreb, Croatia
Interests: allergy; pulmonology; lung function; clinical trials; occupational health; sports medicine
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Pediatric asthma still represents a major clinical challenge in the modern medical landscape despite major research discoveries. Although inhaled steroids have been shown to be the cornerstone in clinical management, being both efficacious and safe, there is still a lot of controversy about their use in both parents and physicians. Still significant problems exist regarding diagnosis, proper choice of therapy regarding different phenotypes, the place of specific allergen immunotherapy, pulmonary rehabilitation, and biologics as the new classes of treatment in moderate to severe pediatric asthma. Low level of control, impaired lung function, and low level of physical activity all present in a significant proportion of patients with pediatric asthma can have a long-lasting impact on health in adulthood and be precursors of COPD. The most common therapeutic strategies are based on inhaled steroids, β2-agonists, muscarinic antagonists, and oral anti-leukotrienes. For the last few years, they have also been based on innovative and highly effective biological therapies with monoclonal antibodies (i.e., anti-IgE, anti-IL4Rα/IL13Rα1, Anti-IL5/IL5Rα). However, many issues are still open, and there is a need for improvement in clinical management in pediatric asthma.

The present special edition aims to describe the most up-to-date clinical advances in pediatric asthma and to outline the most promising and challenging research perspectives for the future.

Prof. Dr. Davor Plavec
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • pediatric asthma
  • clinical management
  • treatment advances
  • diagnostic advances
  • biologic therapy
  • inhaled steroids
  • control of asthma
  • exacerbation prevention
  • quality of life

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop